Similar articles

• [How to advance antidiabetic therapy].

  Tchobroutsky G, Assan R, Tutin M, Hautecouverture M, Slama G. Tchobroutsky G, et al. Nouv Presse Med. 1974 May 25;3(21):1379-82. Nouv Presse Med. 1974. PMID: 4211455 French. No abstract available.
• [Significance of changes in blood serum hexosamines in the pathogenesis of diabetic microangiopathies].

  Riabchuk OG, Starosel'tseva LK. Riabchuk OG, et al. Sov Med. 1970 Mar;33(3):21-4. Sov Med. 1970. PMID: 5419171 Russian. No abstract available.
• [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].

  Gendeleka GF. Gendeleka GF. Vrach Delo. 1989 Aug;(8):54-8. Vrach Delo. 1989. PMID: 2686158 Review. Russian. No abstract available.
• [Atherogenic risk in diabetes: study of arteriosclerotic complications and their relationship with prolonged hypoglycemic treatment].

  Baraldi B, Cristini PD, Maestri G, Maj F, Cocuzza E, Angeli G. Baraldi B, et al. Clin Ter. 1978 Jul 15;86(1):37-53. Clin Ter. 1978. PMID: 743852 Italian. No abstract available.
• [Balanced diabetes and complications of diabetes].

  Koivisto V. Koivisto V. Duodecim. 1990;106(9):643-6. Duodecim. 1990. PMID: 1670354 Review. Finnish. No abstract available.